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The use of commercial, needle-based, oxygen-sensitive electrode
systems in human trials during the past decade has provided a
wealth of new information regarding the role of tumour oxygen
status in predicting survivability and local recurrence. Vaupel et al
(1991), for example, have shown that, in the breast, severe
hypoxia is present only in malignant disease. Further, the presence
of hypoxia is not related to the stage or pathologic grade of the
tumour, suggesting that even if these were determined from biospy
samples, no prediction regarding the presence or absence of radia-
tion-therapy-limiting hypoxia could be made. Several studies in
various anatomic sites have demonstrated a correlation between
tumour hypoxia and response to treatment with ionizing radiation
therapy (H￿ckel et al, 1993a; Okunieff et al, 1993; Brizel et al,
1997). In these studies, extreme hypoxia, as determined by
analysis of pO2 histographs obtained from measurements using
polarographic needle electrodes, indicated poor prognosis. In addi-
tion to predicting local treatment failure, a recent report by Brizel
et al (1996) suggested that hypoxia in primary soft tissue sarcomas
was correlated with the probability of appearance of remote
metastatic disease. Studies in cell culture support the suggestion
that exposure to sustained hypoxia results in the selection of
malignant cells expressing aggressive phenotypes (Graeber et al,
1996).
The sustained interest in tumour hypoxia has given rise to the
introduction of various methods of improving tumour oxygena-
tion. The use of hyperbaric oxygen was an early example
(Thomlinson, 1960), and it continues to be studied in laboratory
animal systems and in human clinical trials (Brizel et al, 1995;
Vo￿te et al, 1995). Inhalation of high oxygen content gases such as
carbogen has also been studied rather extensively (Olive and Inch,
1973; Hill and Bush, 1977; Grau et al, 1992). Chemical agents
such as nicotinamide, which is designed to modify tumour blood
flow, have been used either alone (Horsman et al, 1989) or
together with carbogen inhalation (Rojas, 1992) in an effort to
sensitize tumour cells rendered hypoxic by more than one mecha-
nism (i.e. chronic vs acute). The combination of nicotinamide and
carbogen in conjunction with accelerated radiotherapy is being
evaluated currently in clinical trials in Europe (Saunders and
Dische, 1996). Each of these methods has demonstrated some
success in specific situations and tumour models, while none has
emerged yet as being generally accepted in clinical practice.
The importance of hypoxia in predicting tumour response to
ionizing radiation (and photodynamic) therapy, and in possibly
predicting the likelihood of metastases, has stimulated great
interest in improving techniques for clinical measurement of
tumour oxygenation in vivo. These methods and others suitable
only for laboratory use have been reviewed recently by Stone et al
(1993). While polarographic electrode systems have come to be
viewed as a standard, their widespread, routine clinical acceptance
may be limited by their invasiveness (Saunders and Dische, 1996).
This may be especially important if tumour oxygenation is to be
monitored repeatedly during the course of fractionated therapy.
Near infrared spectroscopy is among the non-invasive methods
that are sensitive to some measure of tumour oxygenation.
Specifically, because the absorption spectra of deoxy- and
oxyhaemoglobin are markedly different, the haemoglobin oxygen
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Summary We have evaluated the ability of steady-state, radially-resolved, broad-band near infrared diffuse reflectance spectroscopy to
measure carbogen-induced changes in haemoglobin oxygen saturation (SO2) and total haemoglobin concentration in a rat R3230 mammary
adenocarcinoma model in vivo. Detectable shifts toward higher saturations were evident in all tumours (n = 16) immediately after the onset
of carbogen breathing. The SO2 reached a new equilibrium within 1 min and remained approximately constant during 200–300 s of
administration. The return to baseline saturation was more gradual when carbogen delivery was stopped. The degree to which carbogen
increased SO2 was variable among tumours, with a tendency for tumours with lower initial SO2 to exhibit larger changes. Tumour
haemoglobin concentrations at the time of peak enhancement were also variable. In the majority of cases, haemoglobin concentration
decreased in response to carbogen, indicating that increased tumour blood volume was not responsible for the observed elevation in SO2. We
observed no apparent relationship between the extent of the change in tumour haemoglobin concentration and the magnitude of the change
in the saturation. Near infrared diffuse reflectance spectroscopy provides a rapid, non-invasive means of monitoring spatially averaged
changes in tumour haemoglobin oxygen saturation induced by oxygen modifiers.
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Correspondence to: TH Foster(HbO2) saturation may be determined from the tissue absorption
spectrum, which may be reconstructed from appropriate
reflectance measurements. Successful spectroscopic determination
of the HbO2 saturation (SO2) in the near infrared spectral region
depends upon two things: (1) the ability to determine accurately
the absorption spectrum in the presence of significant light
scattering by tissue and (2) the ability to account properly for the
contributions of chromophores other than haemoglobin in the
measured tissue absorption spectrum. We have recently reported
on a multi-wavelength, continuous-wave diffuse reflectance spec-
trometer and data reduction scheme that address both of these
criteria (Hull and Foster, 1997; Nichols et al, 1997; Hull et al,
1998). Here, we describe the use of this spectroscopic method to
obtain non-invasively the response of subcutaneous rat mammary
adenocarcinomas to carbogen breathing. The technique is simulta-
neously sensitive to both the HbO2 saturation and to the tumour
haemoglobin concentration.
MATERIALS AND METHODS
Near infrared spectroscopy
Our instrumentation and method of data reduction for performing
quantitative diffuse reflectance spectroscopy in highly scattering
systems has been described in detail elsewhere (Nichols et al, 1997;
Hull et al, 1998). Briefly, we have constructed a continuous wave
spectrometer similar in design to that first suggested by Wilson et al
(1990). Broad-band light from a mercury arc lamp is delivered to
the surface of the tissue via a 400 mm core diameter optical fibre
(the source fibre), which is terminated in a probe of our own design
and construction. The probe also holds a linear array of 20 detec-
tion fibres (200 mm core diameter) located at distances of 1.0—
20.0 mm from the source fibre (see Figure 1). During a measure-
ment, the probe is placed in direct contact with the skin overlying
the tumour. Light from the source fibre is injected into the tissue,
and the diffusely scattered reflectance is collected by the 20 detec-
tion fibres at known distances from the injection point. Monte
Carlo simulations demonstrate that the average depths of the light
paths from the source optical fibre to the most remote detection
fibres (which determine the absorption coefficient) are approxi-
mately 3—4 mm. The output of these detection fibres is then imaged
through a grating spectrograph (SpectraPro¤-275i, Acton Res.
Corp, Acton, MA, USA) onto the surface of a liquid nitrogen-
cooled CCD camera (Princeton Inst., Princeton, NJ, USA). The
imaging spectrograph preserves the positions of the detection fibres
at the detector, and the dispersion of the grating and active area of
the detector are such that 164 nm of spectral information is
recorded simultaneously. Typical signal integration times for
measurements described here are approximately 5 s.
The spatially and spectrally resolved signal at the detector is
treated as a set of separate, radially resolved diffuse reflectance
curves at each of the 164 wavelengths. Each diffuse reflectance
data set is analysed using an expression derived from the diffusion
theory approximation to radiative transport described by Haskell
et al (1994) and by Kienle and Patterson (1997). Fitting this
expression to the spatially resolved diffuse reflectance allows the
absorption coefficient and the transport scattering coefficient of
the medium at one wavelength to be determined independently.
Repeating this analysis for each wavelength over the full detected
spectral range enables the reconstruction of an absorption spec-
trum that is uncorrupted by the effects of multiple light scattering.
Once the absorption spectrum has been constructed in this way,
the oxy- and deoxyhaemoglobin concentrations in the tissue are
determined using a singular value decomposition (SVD) algorithm
adapted from Press et al (1992). This approach has been described
elsewhere (Hull and Foster, 1997; Hull et al, 1998). Briefly, the net
absorption coefficient from the tissue is treated as a sum of contri-
butions from oxyhaemoglobin, deoxyhaemoglobin, and from the
remaining non-haemoglobin absorbers. In its present implementa-
tion, these other absorbers were not specified explicitly, and their
contribution to the tissue absorption was represented by an expan-
sion in terms of sines and cosines where the amplitudes are
returned by the SVD routine. In practice, a total of 10 sine and 10
cosine terms is sufficient to reconstruct the background, non-
haemoglobin absorption. The tissue absorption spectrum, ma(l),
is expressed,
where eHb(l) and eHbO2(l) are the extinction coefficients at wave-
length l of deoxyhaemoglobin and oxyhaemoglobin, respectively,
[Hb] and [HbO2] denote the corresponding concentrations, li
and lf are, respectively, the shortest and the longest wavelengths
in a particular data set, and A0,  Bn and  Cn are the expansion
coefficients. Using the measured values of ma(l) and extinction
coefficients for oxyhaemoglobin published by Wray et al (1998),
and for deoxyhaemoglobin by Matcher et al (1995), as inputs, the
SVD algorithm returns the concentrations of Hb and HbO2 and the
amplitudes of the terms that represent the background absorption.
The saturation (SO2) is then computed from the concentrations of
the haemoglobin species as,
SO2 = [HbO2]/([HbO2] + [Hb]).
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Source fibre
(from arc lamp)
Detection fibres
(to spectrograph)
Tumour
Figure 1 A schematic drawing of the optical probe in contact with the
tumour surface. A total of 20 detection fibres are located at distances of
1.0–20.0 mm from the source fibre
(1)Statistical treatment of diffuse reflectance data
The uncertainties in the diffuse reflectance data acquired by the
CCD camera are calculated using Poisson counting statistics.
Uncertainties in the individual values of ma are returned by the
non-linear least squares algorithm (Press et al, 1992) that is used to
fit the diffusion theory expression described above to the measured
diffuse reflectance. In displaying absorption spectra such as those
shown in Figure 4(A and B), mas from three adjacent wavelengths
are averaged together, and their errors are propagated by conven-
tional means (Bevington, 1969). Errors in the concentrations of
oxy- and deoxyhaemoglobin (Figure 5B) are returned by the SVD
algorithm (Press et al, 1992). Propagation of these errors is done to
determine uncertainties in the HbO2 saturations (Figure 5) and the
changes in the HbO2 saturations and total haemoglobin concentra-
tions (Figures 6 and 7).
Animals and tumours
R3230 mammary adenocarcinomas are serially transplanted
subcutaneously in the abdominal region of female Fischer rats
(100—120 g). For near infrared spectroscopy experiments, 1 mm ´
1 mm  ´ 3 mm tumour sections were implanted using a sterile
trochar technique (Hilf et al, 1965). Implantation of this rectan-
gular tissue section produced ellipsoidal tumour volumes that were
in general more viable at sizes suitable for spectroscopy than
the hemispherical tumours that result from similarly transplanted
1 mm ´ 1 mm  ´ 1 mm sections. Spectroscopy was performed
when tumour dimensions were approximately 20 mm ´ 12 mm,
which, assuming an ellipsoidal geometry, correspond to tumour
volumes of approximately 1.5 cc. In order to immobilize the
animal and to avoid stress associated with confinement, anaes-
thetic (75 mg kg—1 ketamine hydrochloride and 6 mg kg—1
xylazene) was administered prior to data acquisition and was given
in smaller doses (0.4 of initial) as needed (approximately every
20 min). Carbogen (5% CO2, 95% O2) or air was administered via
a nose cone at a flow rate of 3 l min—1. Animal care was conducted
according to guidelines established by the University Committee
on Animal Resources at the University of Rochester.
RESULTS
Differences in the absorption spectra of oxy- and deoxyhaemo-
globin are the basis for near infrared optical monitoring of haemo-
globin oxygen saturation in tissue. Figure 2 presents the spectrum
of oxyhaemoglobin (dashed line) reported by Wray et al (1988)
and that of deoxyhaemoglobin (solid line) reported by Matcher
et al (1995). These spectra were acquired in a conventional
absorption spectrophotometer from non-scattering fluid solutions
containing haemoglobin extracted from red blood cells. The
oxygen content of the solution was established by equilibrating
with either 100% N2 or O2 in a tonometer. Other reports of haemo-
globin absorption spectra in this wavelength range can be found in
the literature; however, we have found that those of Wray et al (for
oxyhaemoglobin) and of Matcher et al (for deoxyhaemoglobin) are
in close agreement with spectra that we have obtained from intact
human erythrocytes using our diffuse reflectance method (Hull
et al, 1998). Therefore, we use these published extinction coeffi-
cients in analysing our data with Eq (1).
Figure 3 shows representative absorption spectra reconstructed
from diffusion theory analysis of diffuse reflectance measurements
made on the skin surface directly over an R3230AC tumour in a
living, anaesthetized animal. Three cases are presented corre-
sponding to (i) the animal breathing room air, (ii) during carbogen
inhalation, and (iii) several minutes after the cessation of carbogen
administration. The absorption peak near 760 nm, which is charac-
teristic of deoxyhaemoglobin, was evident in all spectra recorded
from tumours during inhalation of room air (solid line in Figure 3).
With the onset of carbogen breathing, the amplitude of this peak
rapidly decreased, and the qualitative appearance of the spectrum
reflected a large oxyhaemoglobin contribution (dashed line). At
the end of carbogen delivery, the spectrum gradually returned to its
baseline shape; however, the time required for this restoration was
quite variable in different animals and was sometimes as long as
16 min.
As noted above, accurate determination of haemoglobin oxygen
saturation in tissue requires that the background (non-haemo-
globin) absorption is accounted for correctly. We accomplish this
by representing the background absorption with an expansion in
Near infrared spectroscopy of tumour oxygenation 1711
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Figure 2 Near infrared absorption spectra of deoxy- (¾) and
oxyhaemoglobin (- - -). The oxyhaemoglobin spectrum is from Wray et al
(1988); the deoxyhaemoglobin spectrum is from Matcher et al (1995)
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Figure 3 Absorption spectra reconstructed from diffuse reflectance
measurements performed on an R3230AC tumour prior to carbogen delivery
(¾), during maximum response to carbogen (- - -), and upon restoration of
equilibrium after carbogen was stopped (– - –)sines and cosines, as described in Materials and Methods (Eq (1)).
This method requires no prior knowledge of the spectral features
of the individual absorbing species, although the SVD algorithm
requires that the magnitude of the background represented in this
way be small with respect to the haemoglobin absorption. This
criterion is met in the spectral range of our experiments in vivo.
Figure 4 shows results of applying Eq (1) to the absorption spectra
depicted in Figure 3. The spectrum in Figure 4A was obtained
while the rat breathed room air, while that in Figure 4B was taken
during carbogen inhalation. In both cases, the data points (with
uncertainties) are the individual absorption coefficients (mas)
obtained from analysis of the diffuse reflectance measurements.
The solid lines are the SVD estimate of the absorption from
haemoglobin (oxy- plus deoxyhaemoglobin), while the dot-dashed
lines are the estimates of the absorbing background. The dashed
line through the data points represents the best fit of Eq (1) to the
data. Thus, by separating the contribution of haemoglobin to the
total absorption coefficient from that of the other chromophores,
the method ensures that only the haemoglobin absorption is used
in the calculation of the haemoglobin oxygen saturations. We note
that, at least in this particular case, the background absorption of
the tumour remained approximately unchanged during carbogen
administration.
Haemoglobin oxygen saturations determined from data
recorded before, during and after carbogen inhalation are shown
for a representative tumour in Figure 5A. The vertical, dotted line
at time = 0 s indicates the beginning of carbogen breathing;
the second vertical line indicates the end. Figure 5B shows sepa-
rately the concentrations of Hb, HbO2 and total haemoglobin ([Hb]
+ [HbO2]) for the tumour over the same time course. In this case,
the initial SO2 was slightly greater than 0.75. With the onset of
carbogen breathing, the saturation rose over a period of approxi-
mately 50 s to 0.97, where it remained very constant for the
duration of administration. During the period after carbogen was
1712 EL Hull et al
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Figure 4 Results of the singular value decomposition (SVD) analysis
(Eq (1)) of two of the spectra shown in Figure 3. The symbols (n n) depict the
absorption coefficients (ma) derived from the diffusion theory analysis of the
diffuse reflectance measurements, the solid lines (¾) depict the SVD
estimate of the contribution resulting from haemoglobin (oxy- plus deoxy-),
and the dot-dashed lines (– - –) show the SVD estimates of the tumour
absorption that result from chromophores other than haemoglobin. The
dashed line (- - -) shows the best fit of Eq (1) to the data. The spectrum in (A)
was taken prior to carbogen; the spectrum in (B) was acquired during
maximum response to carbogen. The determination of the error bars is
described in Materials and Methods
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Figure 5 Haemoglobin oxygen saturation (A) and concentrations (B) of
total haemoglobin (l), oxyhaemoglobin (n n), and deoxyhaemoglobin (n) for
a single R3230AC tumour before, during and after carbogen breathing. The
vertical line at time = 0 corresponds to the beginning of carbogen inhalation;
the vertical line at the later time corresponds to the end. The determination
of the error bars is described in Materials and Methodsstopped, the saturation remained at or near its highest level for
30 s, after which it gradually declined over the next 100 s until
reaching an apparent equilibrium, which was slightly elevated
with respect to the initial baseline value. This pattern is reflected in
the concentrations of Hb (n) and HbO2 (n n) plotted in Figure 5B.
In this tumour, the total haemoglobin concentration (l) remained
approximately constant.
Although a possible mechanism for the observed increase in
tumour oxygenation is an increased haemoglobin concentration,
which might be expected in response to vasodilation or to the
resumption of flow in acutely closed tumour blood vessels, our
data demonstrate that such a mechanism was not responsible for
the enhanced saturations. In Figure 6, we plot the maximum
change in tumour SO2 vs the change in the total haemoglobin
concentration for the 16 tumours in the study. The majority (10 of
16) of tumours showed a decreased haemoglobin concentration at
the time corresponding to the peak oxygen enhancement. In three
tumours the haemoglobin concentration remained approximately
constant, while in three others, the concentration increased.
Among all tumours, there was no correlation between the magni-
tude of the change in the haemoglobin concentration (either posi-
tive or negative) and the increase in the measured tumour SO2.
The data in Figure 7 compare the maximum change in tumour
SO2 with the initial saturation measured immediately prior to
carbogen administration. There appear to be roughly two sub-
populations of tumours, one of which exhibits a greater degree of
change in saturation than the other for a given initial SO2. Within
each of these subpopulations, there is a trend toward a larger
carbogen-induced change for tumours with lower initial saturation.
Using a pH of 7.15 for the R3230AC tumour, which has been
determined by Ceckler et al (1991) from 31P NMR spectroscopy
measurements, and the Hill parameters n (2.46) and p50 (33.7 torr)
corresponding to this pH (Zwart et al, 1982, 1984), we fit an
expression of the form
to the data in Figure 7 to find the average change in blood pO2
(DpO2) induced by carbogen. The derivation of this equation is
presented in the Appendix. The fit of Eq (2) to the data is shown as
the solid line in the Figure, and the carbogen-induced change in
pO2 returned by the fit is 29.7 ± 6.6 torr.
DISCUSSION
Spatially averaged tumour haemoglobin oxygen saturation (SO2)
and haemoglobin concentration are reported through non-invasive
measurements of near infrared diffuse reflectance. The near
infrared measurement samples all vessels within the light field and
thus reports an average that is presumably weighted by the relative
arterial and venous volumes. In the series of experiments
described here, the magnitude of the change in SO2 induced by
carbogen was highly variable, although in every tumour (n = 16)
we observed some increase in saturation. The rate of increase in
the saturation was relatively rapid, with the maximum SO2 typi-
cally reached within 1 min after carbogen breathing began. With
the termination of carbogen administration, the return to baseline
SO2 was slower, sometimes taking as long as 15 min. The mecha-
nism through which carbogen inhalation enhanced the SO2 in this
tumour model clearly did not involve increasing the total haemo-
globin concentration, as would occur if, for example, the total
tumour blood volume increased. Indeed, as is evident from the
data shown in Figure 6, in the majority of tumours, the total
haemoglobin concentration decreased in response to carbogen
breathing. This observation may be a consequence of the ￿steal
effect￿, in which vasodilation in the normal circulation results in a
loss of blood volume in the tumour, where physiological regula-
tion is deficient or absent. Among the tumours that exhibited
decreased haemoglobin volume, the extent of volume change was
not related to the magnitude of the increase in the SO2 (Figure 6).
Near infrared spectroscopy of tumour oxygenation 1713
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Materials and Methods
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Figure 7 The maximum carbogen-induced change in haemoglobin oxygen
saturation vs the initial saturation for all tumours included in this study (n =
16). The solid line is a fit of Eq (2) to these data. The fit yielded a carbogen-
induced change in blood pO2 of 29.7 ± 6.6 torr. The determination of the
error bars is described in Materials and Methods
(2)The data suggest a relationship between the extent of the
carbogen-induced change in saturation and the initial SO2 of the
tumour, with a tendency for the largest induced changes to occur in
those tumours with the lowest initial saturations (Figure 7).
Qualitatively, one way that this relationship can be understood is
on the basis of the shape of the haemoglobin—oxygen dissociation
curve (the Hill curve). At the lower oxygen partial pressures where
the Hill curve is roughly linear, an increase in partial pressure will
give rise to a corresponding increase in the SO2. At higher partial
pressures where the slope of the Hill curve becomes more gradual,
the same increase in blood oxygen content will produce a lesser
effect on the saturation. With respect to the magnitude of this
dependence, the data presented in Figure 7 also suggest that there
may be two subpopulations of tumours in our study. This finding
could be a result of the sensitivity of the Hill curve to pH (Benesch
and Bensch, 1974; Zwart et al, 1982), although we have no direct
evidence to support this interpretation. In more acidic environ-
ments, haemoglobin more readily releases oxygen at a given
oxygen partial pressure. Thus, a particular tumour￿s pH will influ-
ence the extent to which an induced change in blood pO2 will be
reflected in an increased SO2. Our observations may be explained
either by differences in the initial pH in subpopulations of
these tumours or by differences in the response to CO2 in these
subpopulations.
In addition to the variability in the extent of the carbogen-
induced change in tumour SO2, the data presented in Figures 6 and
7 show that the initial (pre-carbogen) SO2 and the carbogen-
induced change in total haemoglobin concentration also varied
significantly for the 16 tumours in this study. The reasons for this
pronounced heterogeneity are not clear. There was no obvious
relationship between initial SO2 and tumour volume (data not
shown). Although the initial anaesthetic dose administered to the
animals was constant, some variation in the time between injection
of anaesthetic and the diffuse reflectance measurements was
inevitable. The need for smaller subsequent injections to sustain
chemical restraint was also variable among animals, and it is
possible that one, or the combination of, these anaesthetic-related
effects was responsible for some of the observed variability in the
data. We note, however, that investigators using other techniques
have also reported significant intratumour and intertumour hetero-
geneity in SO2 within the same tumour type (Fenton et al, 1995
and references therein). Clearly, a detailed appreciation of the
physiological information available from near infrared spectro-
scopy is not yet available, and studies designed to further this
understanding appear to be warranted. Comparisons of tumour
SO2 determined in vivo using near infrared spectroscopy with
similar determinations made using cryospectroscopy (Fenton et al,
1995) would be particularly relevant, in that the latter technique
provides haemoglobin saturations in individual vessels in frozen
tumour sections.
As we have implemented the technique, near infrared spectro-
scopy (NIRS) provides a measure of the average haemoglobin SO2
and therefore of the average response to oxygen modifiers such as
carbogen in the volume of tissue sampled by the optical probe. It is
possible to consider approaches to low resolution imaging of
tissue optical properties using near infrared light, which in prin-
ciple may allow spatially resolved determinations of tumour
SO2 (for example, Danen et al, 1998). Whether or not this spec-
troscopy will be a clinically useful predictor of tumour response to
oxygen-dependent interventions such as ionizing radiation therapy
and photodynamic therapy remains to be determined.
Nevertheless, the method possesses attractive features that make it
potentially useful as a research tool and eventually perhaps in
some clinical settings. NIRS is completely non-invasive, thereby
making it suitable in situations where it is desirable to perform
repeated measurements on the same tumour, for example, during a
course of fractionated radiation therapy. Its non-invasive character
also means that it does not perturb tissue oxygen, either by oxygen
consumption or by induction of bleeding, and it is likely to be
well-tolerated by patients. The method reports haemoglobin
oxygen saturation directly, which will likely be useful in
discerning mechanisms of action of various modifiers of tumour
oxygenation. Recently, for instance, Robinson et al (1995, 1997)
have described changes in gradient-echo magnetic resonance
(MR) images in response to carbogen breathing in animal tumour
models. The magnetic resonance signal from flowing blood may
be influenced by its deoxyhaemoglobin content or by its degree of
saturation (i.e. incomplete restoration of equilibrium) from repeti-
tive radiofrequency pulses. Thus, from an enhanced signal in a
gradient echo MR image alone it is in general not possible to
distinguish between a decreased deoxyhaemoglobin concentration
and a reduction in the saturation of the MR signal as a result of
increased blood flow velocity (without a change in deoxyhaemo-
globin) through the region of interest (Robinson et al, 1997).
Because NIRS is capable of determining the SO2 independent of
haemodynamic changes, it could be useful in resolving ambigui-
ties like this one. NIRS provides good temporal resolution, with
signal acquisition times on our system of approximately 5 s.
Finally, the instrumentation required to perform the steady-state
form of diffuse reflectance spectroscopy is relatively inexpensive
and can be as portable as an ultrasound system, thereby making it
possible to consider measurements in the clinic immediately prior
to or during therapy.
Of course, the method is not without its own limitations, espe-
cially in its current form. Although significantly reduced optical
absorption of water and of haemoglobin in the near infrared
spectral region (650—900 nm) enables light to penetrate several
centimetres in tissue, it is unlikely that NIRS will be useful in the
quantitative evaluation of haemoglobin saturation in tumours
residing far from a surface that is accessible to an optical fibre
probe. Further, the particular form of analysis that we have
adopted assumes spatially homogeneous optical properties. This
assumption, however, is not fundamental to the approach. Very
recent work by other investigators has demonstrated diffusion-
theory-based expressions that are capable of extracting optical
properties of layered structures, provided that the thickness of the
upper layer in contact with the optical probe is not too thick
(Kienle et al, 1998). Another limitation imposed by the diffusion
theory approximation to light transport is that, in order to recover
accurate values of the absorption coefficients, relatively large
(approximately 15 mm) separations are required between the
optical fibre that delivers light to the tissue and the most remote
detection fibre. Although this requirement precludes the use of this
technique on smaller tumours at present, it is not fundamental to
the optical method and may be relaxed using other theoretical
approaches. Investigation of suitable alternatives is an active area
of research in several laboratories.
The need for improved methods of monitoring tumour oxygena-
tion in patients continues to be recognized (Saunders and Dische,
1996; H￿ckel et al, 1993b). Even with its current limitations, the
1714 EL Hull et al
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changes induced by carbogen inhalation, is sufficiently encour-
aging that its use could be considered in several anatomic sites
where hypoxia has been recognized as a significant factor influ-
encing the resistance of tumours to ionizing radiation therapy.
These sites include the cervix, head and neck, superficial regions
of the breast, and superficial soft tissue in the extremities.
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APPENDIX
The Hill equation describing the haemoglobin—oxygen dissocia-
tion curve is written,
Near infrared spectroscopy of tumour oxygenation1715
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oxygen partial pressure, p50 is the oxygen partial pressure at which
the SO2 is 0.5, and n is the Hill coefficient. The pH of the
R3230AC tumour is approximately 7.15, as determined by
Ceckler et al (1991) using 31P NMR spectroscopy. The Hill coeffi-
cient, n and the p50 corresponding to this pH are 2.46 and 33.7 torr,
respectively (Zwart et al, 1982, 1984). In our experiments we
measure the initial SO2 (prior to carbogen delivery), which we
denote SO2init, and the final SO2 after full equilibration on
carbogen, which we denote here as SO2f. The change in satura-
tions, DSO2, is written simply
Writing SO2f in terms of the corresponding pO2f through Eq (A1),
this becomes
The pO2f is the sum of the initial pO2 and the carbogen-induced
change, DpO2. Expressing the initial pO2 in terms of the initial SO2
through Eq (A1), we can write pO2f as,
Substitution of the right-hand side of (A4) into Eq (A3) yields
which is the function that is fit to the data in Figure 7 to extract the
carbogen-induced change in blood pO2, DpO2.
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(A1)
(A2)
(A3)
(A4)
(A5)